Public Health Emergency - Leading a Nation Prepared
In cases where patients are infected with antibiotic resistant infections, a rapid diagnosis can save life or limb – and the need for speed skyrockets during a public health emergency. Find out what BARDA is doing to support fast, accurate diagnostics.
What started as a small cut turned into a serious problem for BARDA Director Rick Bright – and it nearly cost him his thumb. Find out how a small cut and a delayed diagnosis threatened his health and may have endangered hospitalized patients around him.
Three Ways for Public Health and Medical Professionals to Enhance Preparedness
When disaster strikes, critical infrastructure failures can keep you from providing effective patient care. ASPR’s Division of Critical Infrastructure Protection (CIP) has built tools, resources, and partnerships to enhance your facility's preparedness.
Public-private partners collaborate to prevent the spread of a global health threat
ERVEBO – developed by Merck & supported by BARDA – has become the first Ebola vaccine approved by the FDA. The vaccine has been given to over 255k people under an expanded access protocol in the fight against Ebola in the DRC.
BARDA is supporting the advanced development of an antibiotic to treat anthrax lung infections and enhance health security. Under this contract, BARDA will fund the studies needed for FDA to consider approval of an emergency use authorization for NUZYRA.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages